Analyses / CLSK
High-growth revenue (+80% YoY), strong margins (48% net), but elevated valuation and volatility (beta 3.9) warrant caution on dips.
A free account reveals CLSK's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Revenue growth 80% YoY, net margin 48%, operating margin 42% suggest strong unit economics. Forward P/E 9.4x is reasonable for growth. Insider buying (18.9M shares bought vs 2.9M sold) signals confidence. Analyst upgrades (KBW $25, Chardan $21 targets) imply 85% upside. Power pipeline expansion (AI data centers) is unpriced catalyst.
▼ Bear Case
Beta 3.9 = high volatility; -3.9% today despite broader gains. Price-to-FCF 66x is punitive; suggests cash conversion concerns. P/B 1.9x and P/S 4.5x elevated vs peers. Crypto/mining tied to BTC volatility. No dividend; all returns depend on appreciation. Drawn down 43% from 52w high ($23.61), signaling prior overvaluation or sentiment shift.
Valuation
mixed—growth premium justified by 80% revenue growth, but FCF/profitability metrics warrant scrutiny — score 62/100
Forward P/E 9.4x is cheap in absolute terms but misleading: no trailing P/E available. P/S 4.5x is elevated vs tech median (~3x). P/B 1.9x reasonable. EV/EBITDA 9.2x is fair for growth. Price-to-FCF 66x signals weak cash conversion or high capex load. Margins (48% net, 42% operating) are exceptional and suggest pricing power, but sustainability depends on scaling without margin compression.
Technical Levels
Support · $12.50 (Recent session low / near-term support) · $11.00 (Psychological / 50-day MA proxy) · $8.00 (52-week low; strong support if tested)
Resistance · $14.20 (Intraday / prev. close) · $16.00 (Short-term resistance zone) · $23.61 (52-week high; bull target anchor)
Financial Health
Score 75/100. Liquidity is fortress-like (CR 4.18, QR 4.14); ample dry powder for capex. No debt metrics in data, limiting full solvency review. Payout ratio 2.95% is atypical (usually <100%); may indicate low earnings base or data anomaly. Balance sheet supports aggressive investment thesis.
Catalysts
| Sandersville AI facility ramp / capacity utilization | Q1–Q2 2025 (estimated) | high |
| Texas expansion / new data center sites announcement | Q1–Q2 2025 | high |
| Next earnings (likely Q4 2024 or Q1 2025) with free cash flow / capex guidance | 1–2 months (estimated) | high |
| Bitcoin price moves / macro crypto sentiment | Ongoing | medium |
Risk Flags
See CLSK's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock CLSK free →Recent News
- Keefe, Bruyette & Woods Maintains Outperform on Cleanspark, Raises Price Target to $25Benzinga
- MARA Holdings: 4.8 Gigawatt Power Pipeline Is Not Priced InSeekingAlpha
- Chardan Capital Maintains Buy on Cleanspark, Raises Price Target to $21Benzinga
- CleanSpark (CLSK) Stock Drops Despite Market Gains: Important Facts to NoteYahoo
- Why CleanSpark's Sandersville AI site is just the beginning: Texas is nextYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full CLSK analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
CLSK FAQ
Is CLSK a buy right now?
CleanSpark Inc's current read is a growth_with_elevated_risk setup with 62 confidence over a 3–6 months horizon. Valuation: mixed—growth premium justified by 80% revenue growth, but FCF/profitability metrics warrant scrutiny. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is CLSK overvalued?
mixed—growth premium justified by 80% revenue growth, but FCF/profitability metrics warrant scrutiny (valuation score 62/100). Forward P/E 9.4x is cheap in absolute terms but misleading: no trailing P/E available. P/S 4.5x is elevated vs tech median (~3x). P/B 1.9x reasonable. EV/EBITDA 9.2x is fair for growth. Price-to-FCF 66x signals weak cash conversion or high capex load. Margins (48% net, 42% operating) are exceptional and suggest pricing power, but sustainability depends on scaling without margin compression.
What are the risks of buying CLSK?
Beta 3.9 = high volatility; -3.9% today despite broader gains. Price-to-FCF 66x is punitive; suggests cash conversion concerns. P/B 1.9x and P/S 4.5x elevated vs peers. Crypto/mining tied to BTC volatility. No dividend; all returns depend on appreciation. Drawn down 43% from 52w high ($23.61), signaling prior overvaluation or sentiment shift.